Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

NEW YORK, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Blue Point Brewing Company (“Blue Point”), a subsidiary of Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ: TLRY and TSX: TLRY), is thrilled to announce the return of its highly anticipated 19th Annual Cask Ales Festival. The event, in partnership with Long Island Cares, is set to take place on Saturday, November 4th, and promises a mix of live music, local vendors, food trucks, and, of course, a wide array of cask ales from breweries around the country.

Blue Point Brewing Announces Cask Ales Festival and New Beer Lineup

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

AdvisorShares Pure US Cannabis ETF

Constellation Brands

Valley National

Over the last few months, the allure of cannabis stocks has gained momentum. Since mid-2023, many top-tier cannabis companies have experienced rejuvenation in pricing and demand.

7 Cannabis Stocks to Buy Before They Burn Higher

Innovative Industrial Properties

Global X Cannabis ETF

Cannabis stocks will eventually see higher highs — with patience. Right now, we're waiting to see if the Drug Enforcement Administration (DEA) takes the U.S. Department of Health and Human Services' (HHS) advice to remove cannabis as a Schedule I drug, which could boost related stocks.

3 Cannabis Stocks to Buy Before the Big Breakout

Anghami

Recursion Pharmaceuticals

Speculative stocks are a risky proposition in today's market. With even the Standard and Practices (S&P) 500's stablest giants dropping, small-cap risky stocks don't stand a chance.

3 Extra-Speculative Stocks That Could Make You Very, Very Rich

Cronos Group

Cannabis stocks have remained depressed for an extended period and have been investor wealth destroyers. Regulatory headwinds have been the key reason for stocks underperforming.

3 Cannabis Penny Stocks With Millionaire-Making Potential

Here's a buy-low-and-just-hold-it opportunity that will reward patient individuals. Tilray (NASDAQ: TLRY ) stock is trading at a low price in October, and investors should start accumulating shares before they double, triple or more.

Why Undervalued Tilray Stock Is a Hidden Cannabis Gem in Plain Sight

BlackBerry

GameStop

Warren Buffett likes to say that his favorite holding period for a stock is “forever.” However, Buffett mostly owns slow growing blue-chip stocks that pay high dividends such as Coca-Cola (NYSE: KO ).

3 Stocks to Buy Today and Sell Tomorrow

ATLANTA, Oct. 24, 2023 (GLOBE NEWSWIRE) -- SweetWater Brewing Company (“SweetWater”), the largest craft brewer in the Southeast and a subsidiary of Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ: TLRY and TSX: TLRY), today unveiled its highly anticipated fall lineup of craft brews and the release of the new limited series Brewer's Batch Golden Ale and Brewer's Batch IPA, as well as the return of its popular Georgia Brown Ale , Mosaic Single Hop Hazy IPA, and Fresh Sticky Nugs Hazy Double IPA . “Our new fall lineup features a strong blend of time-honored favorites and delicious new brews that are perfect for the season, whether you're watching football, winding down after a day outdoors, or enjoying a crisp evening with friends,” said Ty Gilmore, President, Tilray Beer.

Sweetwater Brewing Company Unveils Fall Craft Beer Lineup

Aurora Cannabis

Village Farms International

As November 2023 draws near, the Canadian marijuana market and top marijuana stocks are again in the news, with several leading stocks grabbing analysts' and investors' attention. The decision to legalize recreational marijuana in Canada in 2018 has contributed to the industry's impressive expansion in recent years. According to Statistics Canada, the business generated more than $2.8 billion in sales in 2020, which has only increased. This booming market and the continued expansion of Canadian cannabis businesses into the United States create a compelling investment environment.

Top Canadian Cannabis Stocks to Watch in November

Tilray Brands (NASDAQ: TLRY ) presents an intriguing opportunity, especially when looking at TLRY stock in the cannabis sector. Tilray has established itself as a pioneer in the global cannabis and consumer goods sector, with a relatively diverse product line.

Tilray Stock's Tumble: A Buying Opportunity or a Cautionary Tale?

Bitfarms Ltd

Solid Power

The risk with penny stocks is significant. If the business can take off, the stock can mint millionaires.

3 Penny Stocks With 10-Bagger Potential in Five Years

TORONTO, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, is celebrating five years of remarkable growth and industry leadership in the Canadian cannabis market since legalization. Over the past half-decade, Tilray has emerged as the most robust and leading international cannabis Licensed Producer (LP) in Canada with a cannabis market share of approximately 13.4%, inclusive of recent strategic acquisitions of HEXO Corp. and Truss Beverage Co.

Celebrating Five Years of Growth: Tilray Brands Reflects on Industry Leadership in Canadian Cannabis and Looks Forward to its Future

Lucid Group

Nokia

In the fast-paced world of stock trading, every investor dreams of discovering that hidden gem, especially when it comes to penny stocks. Navigating this realm reminds one of the timeless Warren Buffett adage: “Risk comes from not knowing what you're doing.

3 Penny Stocks Poised to Become Multi-Baggers

Canopy Growth

SNDL Inc.

As we enter the fourth quarter of 2023 the cannabis sector is progressing into the future. More companies are working on various ventures and developing new products. Not only that there is the continued effort to establish federal cannabis reform more notably the SAFER Banking Act. Due to the current conflict between Israel and Palestine and other political priorities like the 2024 presidential election. So the issue of passing any type of federal reform has once again taken a back seat.

These Marijuana Stocks Could See Better Trading Come 2024

HEXO Corp

OrganiGram Holdings Inc.

Tuesday, October 17, 2023 marks five years since recreational cannabis was legalized in Canada and it's been tough going for operators in the budding sector. Industry players have had to contend with oversaturation, competition from the black market, limited opportunities to enter the United States market, and, more recently, challenging broader economic conditions due to high inflation and interest rates.

Cannabis stocks struggle as Canada marks five years of legal recreational use

Cannabis stocks have been stagnant or declining due to cash burn and regulatory challenges. Despite this, many bulls have once again begun expecting a resurgence in this sector.

3 Overbought Cannabis Stocks That Are Due for a Reckoning

PayPal

Trulieve Cannabis Corp.

Tesla

The cannabis industry operates in a quasi-legal environment that makes it difficult for companies to grow. The federal ban on pot creates many hurdles for businesses.

Is Elon Musk the Hero the Cannabis Industry Needs Right Now?

CANTANHEDE, Portugal, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Tilray Medical, a division of Tilray Brands, Inc. ("Tilray" or the "Company") (Nasdaq: TLRY; TSX: TLRY) and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, today announced their contribution to an independent clinical trial to research the efficacy of medical cannabis as a treatment for glioblastoma, a severe form of brain cancer. The clinical trial will be conducted in Spain, recruiting 30 patients from eight specialized neuro-oncology medical sites, in partnership with renowned scientists from the Spanish Research Group of Neuro-Oncology (GEINO) and the Complutense University of Madrid, with Tilray Medical providing the pharmaceutical-grade medical cannabis for the trial (THC/CBD 1:1) for administration to patients. The trial is funded by the Medical Cannabis Bike Tour Foundation charity and is scheduled to commence at University Hospital 12 de Octubre, on September 5, 2023.

Tilray Medical Supports New Clinical Trial to Study Medical Cannabis in Glioblastoma Cancer Treatment

Kinross Gold

Standard Lithium Ltd

Every investor dreams of making millions from the markets. And that dream is realistic with a proper investment strategy and patience.

7 Penny Stocks To Make You The Millionaire Next Door: October Edition

Tilray (NASDAQ: TLRY) stock price has erased most of the gains it made in September as hopes of regulatory clarity rose. After surging to $3.40 on September 5th, the cannabis stock has plunged by ~41% and is now at its lowest level since July 27th.

Tilray stock price forecast: TLRY could crash by ~25% soon

AFC Gamma

Amplify Alternative Harvest ETF

NewLake Capital Partners, Inc.

Cannabis stocks may be one of the most controversial trades on the market. But it could also turn out to be one of the most profitable.

Green Gold Rush: Top 7 Cannabis Stocks Primed for Explosive Growth

Inspired by Montauk's Best-Selling Beer, Major Wave Chaser Will Quench Growing Thirst for Full Flavors and High Alcohol Inspired by Montauk's Best-Selling Beer, Major Wave Chaser Will Quench Growing Thirst for Full Flavors and High Alcohol

Montauk Releases Major Wave Chaser Double India Pale Ale

Tilray's short interest has reached a new 52-week high, indicating growing skepticism and concerns over the company's financial situation. The number of outstanding shares has significantly increased due to dilution, leading to frustration among investors. Tilray's recent financial results were mixed, but the acquisition of beer brands has diversified its revenue base and led to rising revenue estimates.

Tilray Shorts Surge On More Dilution

Cannabis companies in Canada have been struggling to gain market share. Competition is fierce, and growth rates have deteriorated significantly in recent years.

Canada Legalized Marijuana 5 Years Ago. Why Is the Industry Now in Such Bad Shape?

Tilray's marijuana business is still unprofitable. Its alcohol segment is a rising star.

3 Key Metrics to Watch for Tilray Stock

News for Tilray Brands Stock (TLRY)